BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2984484)

  • 41. Pancreatic enzyme synthesis in pancreatic disease.
    Boyd EJ; Clark G; Dunbar J; Wormsley KG
    Scand J Gastroenterol; 1985 Aug; 20(6):734-40. PubMed ID: 4035292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic polypeptide secretion in patients with chronic pancreatitis and after pancreatic surgery.
    Eddes EH; Verkijk M; Gielkens HA; Biemond I; Bemelman W; Lamers CB; Masclee AA
    Int J Pancreatol; 2001; 29(3):173-80. PubMed ID: 12067221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human pancreatic polypeptide: studies of fasting and postprandial plasma concentrations.
    Track NS; McLeod RS; Mee AV
    Can J Physiol Pharmacol; 1980 Dec; 58(12):1484-9. PubMed ID: 7237243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors.
    Langstein HN; Norton JA; Chiang V; O'Dorisio TM; Maton PN; Marx SJ; Jensen RT
    Surgery; 1990 Dec; 108(6):1109-15; discussion 1115-6. PubMed ID: 2174193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pancreatic polypeptide update: its roles in detection of the trait for multiple endocrine adenopathy syndrome, type I and pancreatic polypeptide-secreting tumors.
    Friesen SR; Tomita T; Kimmel JR
    Surgery; 1983 Dec; 94(6):1028-37. PubMed ID: 6139885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods.
    Mariani A; Mezzi G; Masci E; Soldarini A; Calori G; Zerbi A; Tittobello A
    Pancreas; 1999 Mar; 18(2):203-11. PubMed ID: 10090419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional reserve capacity of the exocrine pancreas.
    Lankisch PG; Lembcke B; Wemken G; Creutzfeldt W
    Digestion; 1986; 35(3):175-81. PubMed ID: 3781113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure.
    Regan PT; DiMagno EP
    Gastroenterology; 1980 Mar; 78(3):484-7. PubMed ID: 7351287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum cathodic trypsin-like immunoreactivity, pancreatic lipase, and pancreatic isoamylase as diagnostic tests of chronic pancreatitis or pancreatic steatorrhea.
    Møller-Petersen J; Pedersen JO; Pedersen NT; Andersen BN
    Scand J Gastroenterol; 1988 Apr; 23(3):287-96. PubMed ID: 3291084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating trypsin-like immunoreactivity in chronic pancreatitis.
    Andriulli A; Masoero G; Felder M; Vantini I; Petrillo M; Cavallini G; Bianchi Porro G; Dobrilla G; Verme G
    Dig Dis Sci; 1981 Jun; 26(6):532-7. PubMed ID: 7238274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Motilin, human pancreatic polypeptide (HPP) and gastrin plasma concentrations in fasting subjects.
    Track NS; Watters LM; Gauldie J
    Clin Biochem; 1979 Aug; 12(4):109-17. PubMed ID: 487559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between gastrointestinal humoral factors and pancreatic proteolytic enzymes in alcohol-related versus non-alcohol-related pancreatitis.
    Bharmal SH; Pendharkar SA; Singh RG; Petrov MS
    Alcohol; 2019 May; 76():1-10. PubMed ID: 30529016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversibility of exocrine pancreatic failure in chronic pancreatitis.
    García-Pugés AM; Navarro S; Ros E; Elena M; Ballesta A; Aused R; Vilar-Bonet J
    Gastroenterology; 1986 Jul; 91(1):17-24. PubMed ID: 3486791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serum levels of pancreatic polypeptide in normal subjects and in patients with pancreatic and renal disease].
    Fan SL
    Zhonghua Nei Ke Za Zhi; 1984 Oct; 23(10):615-8. PubMed ID: 6532673
    [No Abstract]   [Full Text] [Related]  

  • 55. Endoscopic retrograde cholangiopancreatography in the evaluation of pancreatic disease.
    Novis BH; Narunsky L; Bank S
    S Afr Med J; 1976 Sep; 50(39):1501-5. PubMed ID: 982198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum trypsin concentration and pancreatic trypsin secretion in insulin-dependent diabetes mellitus.
    Frier BM; Adrian TE; Saunders JH; Bloom SR
    Clin Chim Acta; 1980 Aug; 105(2):297-300. PubMed ID: 7398096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is zinc concentration in pancreatic fluid a marker for pancreatic diseases?
    Pungpapong S; Scolapio JS; Woodward TA; Wallace MB; Raimondo M
    JOP; 2005 Sep; 6(5):425-30. PubMed ID: 16186663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.
    Hedo JA; Villanueva ML; Marco J
    J Clin Endocrinol Metab; 1978 Aug; 47(2):366-71. PubMed ID: 400718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elastase secretion in pancreatic disease.
    Mizuno R; Hayakawa T; Noda A
    Am J Gastroenterol; 1985 Feb; 80(2):113-7. PubMed ID: 3844284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum and correspondent tissue measurements of epidermal growth factor (EGF) and epidermal growth factor receptor (EGF-R). Clinical relevance in pancreatic cancer and chronic pancreatitis.
    Birk D; Gansauge F; Gansauge S; Formentini A; Lucht A; Beger HG
    Int J Pancreatol; 1999 Apr; 25(2):89-96. PubMed ID: 10360220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.